Clinical Research Directory

A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea

Sponsor: Takeda

Summary

The purpose of this study is to estimate the proportion of all adverse events (AEs) including serious adverse events (SAEs) occurring with the use of brigatinib among adult participants who have been administered brigatinib as per the approved indications.

Official title: Post-Marketing Surveillance (Usage Results Study) of Brigatinib in the Treatment of Adult Patients for Approved Indications in South Korea

Key Details

Conditions

Interventions

Locations (1)